• Journal Details
  • Access type:Open Access
  • Format:Journale
  • ISSN:1820-8665
  • eISSN:2335-075X
  • First Published:23 Apr 2014
  • Languages:English
  • Subjects:Medicine, Clinical Medicine, other
  • Journal Metrics
  • Cite Score:0.5
  • SJR:0.131
  • SNIP:0.127
  • Index Copernicus:85.33


Aims & Scope

Serbian Journal of Experimental and Clinical Research (Ser J Exp Clin Res) is a peer-reviewed, open access journal which publishes original research articles, reviews, case reports and letters to the editor in all areas of the biomedical sciences that have not been published previously. Ser J Exp Clin Res was founded in 2000 under the name Medicus and over more than two decades has grown into one of the leading national journals in the field of biomedical sciences. Ser J Exp Clin Res is owned and published by Faculty of Medical Sciences University of Kragujevac. The journal adheres to the policies of the International Committee of Medical Journal Editors (ICMJE) and publishing ethics guidelines provided by the Committee on Publication Ethics (COPE).

SJECR publishes papers from all fields of biomedical science and practice in form of original papers, short communications, reviews/meta-analyses, case reports,medical history articles, personal views, letters to the editor, reports from scientific meetings that have not been published previously. SJECR is an Open Access Journal and it is published four times a year.

The first issue of SJECR was published in March 2000.

SJECR is owned and published by Faculty of Medical Sciences University of Kragujevac. However, Editors have full academic freedom and authority for determining the editorial content of the journal, according to their scientific, professional and ethical judgment.

Editorial policy and decision making follow procedures which are endeavoring to ensure scientific credibility of published content, confidentiality and integrity of authors, reviewers, and review process, protection of patients` rights to privacy and disclosing of conflict of interests.

Copyright Policy
All articles published in Serbian Journal of Experimental and Clinical Research are open-access articles, published and distributed under the terms of the Creative Commons Attribution 4.0 International License, which permits reproduction, distribution, derives and commercial use, provided the original work is properly cited and authors and publisher are properly identified. On the following link Open Access License can be found: Open Access License.

Archiving
Sciendo archives the contents of this journal in Portico - digital long-term preservation service of scholarly books, journals and collections.

Plagiarism Policy
The editorial board is participating in a growing community of Similarity Check System's users in order to ensure that the content published is original and trustworthy. Similarity Check is a medium that allows for comprehensive manuscripts screening, aimed to eliminate plagiarism and provide a high standard and quality peer-review process.

Editorial Board

Journal Manager
Vladimir Jakovljevic, Faculty of Medical Sciences, University of Kragujevac, Serbia

Editor-in-Chief
Vladimir Zivkovic, Faculty of Medical Sciences, University of Kragujevac, Serbia

Editors - Editorial Board:
Ivan Srejovic, Faculty of Medical Sciences, University of Kragujevac, Serbia
Tamara Nikolic Turnic, Faculty of Medical Sciences, University of Kragujevac, Serbia
Jovana Jeremic, Faculty of Medical Sciences, University of Kragujevac, Serbia
Mirjana Veselinovic, Faculty of Medical Sciences, University of Kragujevac, Serbia

Editorial Advisory Board (Surnames are given in alphabetical order)
Antovic J (Stockholm, Sweden)
Bosnakovski D (Stip, FYR Macedonia)
Chaldakov G (Varna, Bulgaria)
Conlon M (Ulster, UK)
Dhalla NS (Winnipeg, Canada)
Djuric D (Belgrade, Serbia)
Fountoulakis N (Thessaloniki, Greece)
Kozlov R (Smolensk, Russian Federation)
Kusljic S (Melbourne, Australia)
Lako M (Newcastle, UK)
Mitrovic I (San Francisco, USA)
Muntean D (Timisoara, Romania)
Paessler S (Galvestone, USA)
Pechanova O (Bratislava, Slovakia)
Serra P (Rome, Italy)
Strbak V (Bratislava, Slovakia)
Svrakic D (St. Louis, USA)
Tester R (Glasgow, UK)
Vlaisavljevic V (Maribor, Slovenia)
Vujanovic N (Pittsburgh, USA)

Editorial Management - Managing Editors
Vladimir Jakovljevic
Vladimir Zivkovic
Nebojsa Zdravkovic
Vladislava Stojic
Marijana Andjic
Nevena Draginic
Marina Nikolic
Ana Miloradovic
Milan Milojevic

Corrected by
Neda Vidanovic
Natasa Djurovic

Address
Serbian Journal of Experimental and Clinical Research, Faculty of Medical Sciences
University of Kragujevac 69 Svetozara Markovica Street, 34000 Kragujevac, PO Box 124, Serbia

Contact
sjecr@medf.kg.ac.rs

Publisher
De Gruyter Poland
Bogumila Zuga 32A Str.
01-811 Warsaw, Poland
T: +48 22 701 50 15

Abstracting & Indexing

Serbian Journal of Experimental and Clinical Research is covered by the following services:

  • Baidu Scholar
  • Cabell's Whitelist
  • Case
  • Chemical Abstracts Service (CAS) - CAplus
  • Chemical Abstracts Service (CAS) - SciFinder
  • CNKI Scholar (China National Knowledge Infrastructure)
  • CNPIEC - cnpLINKer
  • Dimensions
  • DOAJ (Directory of Open Access Journals)
  • EBSCO (relevant databases)
  • EBSCO Discovery Service
  • Genamics JournalSeek
  • Google Scholar
  • Japan Science and Technology Agency (JST)
  • J-Gate
  • JournalGuide
  • JournalTOCs
  • KESLI-NDSL (Korean National Discovery for Science Leaders)
  • Meta
  • Microsoft Academic
  • MyScienceWork
  • Naver Academic
  • Naviga (Softweco)
  • Primo Central (ExLibris)
  • Publons
  • QOAM (Quality Open Access Market)
  • ReadCube
  • SCImago (SJR)
  • SCOPUS
  • Semantic Scholar
  • Sherpa/RoMEO
  • Summon (ProQuest)
  • TDNet
  • Ulrich's Periodicals Directory/ulrichsweb
  • WanFang Data
  • WorldCat (OCLC)

Login / Submit
Instructions for Authors

Please submit your manuscripts to Serbian Journal of Experimental and Clinical Research via Editorial Manager System www.editorialmanager.com/sjecr/.
Open Access Statement
The journal is an Open Access journal that allows a free unlimited access to all its contents without any restrictions upon publication to all users.
Open Access License
Article Processing Charges (APCs)
The accepted manuscripts are published online first as Ahead of Print papers and are free of charge for authors.
For more information please visit https://sciendo.com/journal/sjecr
Instructions for Authors
TYPES OF MANUSCRIPTS
  • Original research articles: Ser J Exp Clin Res considers all original research manuscripts which present the results of an original research study (experimental or clinical). These manuscripts must contain sufficient information on all relevant research methods, as well as a detailed analysis of the results obtained.
  • Reviews: Ser J Exp Clin Res considers literature reviews, systematic reviews and meta analyses addressed to a particular subject area, with special reference to new knowledge and facts. Manuscripts in this category must not be shorter than 6000 words, the text must cite more than 70 references of which 50% have been published in the previous 5 years. Systematic reviews should follow the PRISMA guidelines.
  • Case reports: Ser J Exp Clin Res considers case reports presenting detailed information on the symptoms, signs, diagnosis, treatment (including all types of interventions), and outcomes of an individual patient. Case reports should usually describe new or uncommon conditions that serve to enhance medical care or highlight diagnostic approaches. Case reports should follow the CARE guidelines.
  • Letters to the editor: Ser J Exp Clin Res considers letters to the editor related to different clinical and laboratory observations. They should be titled, not exceed 500 words, and have a maximum of 5 references. Up to 1 table or figure may be submitted, but will be published at the discretion of the Editor. No more than 3 authors should appear.
MANUSCRIPT SUBMISSION
Manuscripts submitted to Ser J Exp Clin Res must neither be published previously nor be under consideration for publication in another journal. Manuscripts are accompanied with a suitable cover letter stating that: the manuscript is not submitted for publication elsewhere; all authors have agreed to submission; the study is carried out in accordance with relevant ethical international guidelines.
Ser J Exp Clin Res considers only manuscripts written in English using Microsoft Office Word format and uploaded online at https://www.editorialmanager.com/sjecr/.
Plagiarism, data fabrication and image manipulation are not tolerated. Plagiarism includes copying text, ideas, images, or data from another source, even from authors own publications, without providing any reference to the original source. If a study's design or the manuscript's structure or language has been inspired by previous works, these papers must be explicitly cited. All manuscripts submitted to Ser J Exp Clin Res are checked for plagiarism using the academic standard software prior to the first step of the editorial process.
MANUSCRIPT PREPARATION AND ORGANISATION
Title Page
The Title Page should contain the following information:
  • Manuscript title
  • Full author(s) names
  • The affiliation(s) of the author(s)
  • A clear indication and an active e-mail address of the corresponding author
Manuscript title should be concise and informative.
It is necessary to state the full names and surnames (middle letter or name is optional) of all authors and the exact affiliations of all authors - institution, (department), city, (state), country. Ser J Exp Clin Res remains neutral with regard to jurisdictional claims in institutional affiliations. Responsibility for affiliations ultimately rests with the author.

Abstract
Provide an abstract of 150 to 250 words. Abstract should be structured (Background, Methods, Results, Conclusion), citation-free, without abbreviations if possible.

Keywords
Three to five relevant keywords need to be added after the abstract. Keywords should be specific to the manuscript, yet reasonably common within the subject discipline.

Text Formatting
Manuscripts should be submitted in Microsoft Office Word. The authors should use normal, plain Times New Roman font (12pt) for text. Pages should be numbered automatically. Italics may be used for emphasis. Abbreviations should be defined at the first mentioning in the text and used consistently thereafter (do not use a separate subtitle for abbreviations only). Please use no more than three levels of displayed headings. International System (SI) of Units should be used (imperial, US customary and other units should be converted to SI units).
Original research articles should contain following sections: Introduction, Materials and Methods, Results, Discussion, Conclusions, Acknowledgments, Conflict of Interest, and References. Reviews may require different formats, while Case reports manuscripts should follow the CARE guidelines.
Introduction. This section should contain context or background for the study, rationale, clear aim of research or tested hypothesis.
Materials and Methods. This section should provide sufficient detail for replication of the study. If more than one method is used in the research, use subsections with appropriate subheadings. The Materials and Methods section should also contain following statements:
1. Informed Consent Statement. In cases where the identification of personal information is necessary for scientific reasons, authors should obtain informed consent from all individuals included in the study.
2. Human Right Statement. Manuscripts containing information related to human should clearly state that the research has complied with all relevant international and national regulations and institutional policies and has been approved by the authors' institutional Ethics committee.
3. Animal Right Statement. Manuscripts containing information related to animals should clearly state that the research has complied with all relevant international and national regulations and institutional policies and has been approved by the authors' institutional Ethics committee.
For details and examples of statements please see part ‘Research and publication ethics’.
Results. The results should be presented in logical sequence in the manuscript. Do not repeat all the data in the tables or figures in the text.
Discussion. This section should explain obtained results, and not repeat them and interpret their significance and draw conclusions. It should discuss the study results in the light of previously published papers. Conclusions. Within the Conclusions section the authors should clearly explain the main conclusions of the article, highlighting its importance and relevance.
Acknowledgments. Acknowledgments of people, grants, funds, etc. should be placed in a separate section after the Conclusions section. The names of funding organizations should be written in full. This may include administrative and technical support, or donations in kind (e.g., materials used for experiments).
Conflict of Interest. Authors must declare all relevant interests that could be perceived as conflicting. If there is no conflicts exist, the authors should state this. Submitting authors are responsible for coauthors declaring their interests.
References. References must be numbered in order of appearance in the text (including table captions and figure legends) and listed individually at the end of the manuscript. In the text, reference numbers should be placed in round brackets ( ), and placed before the punctuation e.g. (1), (1 3) or (1, 3). The list of references should only include works that are cited in the text and that have been published or accepted for publication. Personal communications and unpublished works should only be mentioned in the text.
The reference list should include contain surnames and the first letter of the author's name, full title, abbreviated title of the journal, year of publication, volume, number and pagination (Vancouver style guide). In case where the list of authors are more than six, please use et al. after the sixth author.
The examples of correct referencing:
For journal papers:
Shoji F, Haro A, Yoshida T, Ito K, Morodomi Y, Yano T, et al. Prognostic significance of intratumoral blood vessel in- vasion in pathologic stage IA non-small cell lung cancer. Ann Thorac Surg. 2010;89(3):864-9.
For journal papers by DOI:
Ewy MW, Patel A, Abdelmagid MG, Mohamed Elfadil O, Bonnes SL, Salonen BR, et al. Plant-Based Diet: Is It as Good as an Animal-Based Diet When It Comes to Protein? Curr Nutr Rep. 2022. doi: 10.1007/s13668-022-00401-8.
For books:
Kleiner FS, Mamiya CJ, Tansey RG. 2001. Gardner’s art through the ages (11th ed.). Fort Worth, USA: Harcourt College Publishers.
For chapter in an edited book:
Mettam GR, Adams LB. How to prepare an electronic version of your article. In: Jones BS, Smith RZ, editors. Introduction to the electronic age, New York: E-Publishing Inc; 2009, p. 281 304.
Tables, figures and images
Tables
Tables should always be cited in text in consecutive numerical order. For each table, please supply a table caption (title) explaining the components of the table. Identify any previously published material by giving the original source in the form of a reference at the end of the table caption. Footnotes to tables should be indicated by superscript lower-case letters (or asterisks for significance values and other statistical data) and included beneath the table body.

Figures
Please submit each figure as an individual file separate from the manuscript text. All figures are to be numbered using Arabic numerals. Figures should always be cited in text in consecutive numerical order. Each figure should have a concise caption describing accurately what the figure depicts. Include the captions in the text file of the manuscript, not in the figure file.
For vector graphics, the preferred format is EPS, for halftones, please use TIFF format. Microsoft Office files are also acceptable. Vector graphics containing fonts must have the fonts embedded in the files.
Line art:
  • Definition: Black and white graphic with no shading.
  • Do not use faint lines and/or lettering and check that all lines and lettering within the figures are legible at final size.
  • All lines should be at least 0.1 mm (0.3 pt) wide.
  • Scanned line drawings and line drawings in bitmap format should have a minimum resolution of 1200 dpi.
  • Vector graphics containing fonts must have the fonts embedded in the files.
Halftone art:
  • Definition: Photographs, drawings, or paintings with fine shading, etc.
  • If any magnification is used in the photographs, indicate this by using scale bars within the figures themselves.
  • Halftones should have a minimum resolution of 300 dpi.
Images
Supply vector-based files such as those produced by CorelDraw, Adobe Illustrator or similar software. Vector files give us maximum flexibility for sizing your figures properly. Do not rasterize line art or text. Photographic images should have a minimum resolution of 300 dpi at final print size. Embedded images within a vector file should also have a minimum resolution of 300 dpi. Up sampling artwork (artificially increasing file size or resolution) will not improve quality and causes production problems. At final print size, line weights can be no thinner than 0.28 pt.
PEER REVIEW PROCESS
All submitted manuscripts received by the Editorial Office will be evaluated by a professional Editorial board?to determine whether they posses sufficient quality, are they properly prepared and follow the ethical policies of Ser J Exp Clin Res. Manuscripts that do not fit with the quality and ethical standards of Ser J Exp Clin Res will be rejected before peer-review. Manuscripts that are not properly prepared according to the Instruction for authors will be returned to the authors for revision and resubmission.?
Once a manuscript passes the initial evaluation, it will be assigned to at least two independent experts for single-blind peer-review process. If the outcomes of the performed reviews are opposite, the third review is required. The peer-review outcomes are one of following:
  • Accept (without any changes) - the journal will publish the paper in its original form. This type of decision outcome is rare.
  • Minor revision - the manuscript have high chance to be accepted after fulfillment of minor corrections. Authors will be asked to resubmit the revised manuscript within a suitable time frame, and the revised version will be returned to the reviewer for further comments.
  • Reconsider after Major Revision - the acceptance of the manuscript would depend on the revisions. The authors are required to perform extensive and significant improvements in their manuscript. Authors will be asked to resubmit the revised manuscript within a suitable time frame, and the revised version will be returned to the reviewer for further comments.
  • Reject - the manuscript is rejected for two reasons: 1. it has serious flaws, and/or makes no original significant contribution; 2. corrections and improvements during the (major) revision were not sufficient and satisfactory. No offer of resubmission to the journal is provided.
All reviewer comments should be responded point-by-point in a separate document entitled ‘Answers to reviewers comments’. Corrections should be marked within the text in a red colour or as a track changes. During the submission process, author should suggest two potential reviewers with the appropriate expertise to review the manuscript. Proposed reviewers should be from different institutions than the authors.
Upon editor’s approval, after received positive manuscript reviews, the manuscript is accepted in the system, and the corresponding author receives information about the manuscript accepted for publication to the email address. Once accepted, the manuscript will undergo professional copy-editing, English editing, proofreading by the authors, pagination and publication. The Editorial board reserves the right to correct the English language after proofreading by the authors.
DOI number is assigned to the paper and, after proofreading and text break according to the Journal instructions, the paper is published as Ahead of Print first on Sciendo platform (https://sciendo.com/journal/sjecr) and then in one of the next issues of the Journal.
Description of the Peer Review process
All submitted manuscripts received by the Editorial Office are evaluated by a professional Editorial board?to determine whether they posses sufficient quality, are they properly prepared and follow the ethical policies of Ser J Exp Clin Res. Manuscripts that do not fit with the quality and ethical standards of Ser J Exp Clin Res are rejected before peer-review. Manuscripts that are not properly prepared according to the Instruction for authors are returned to the authors for revision and resubmission.?
Once a manuscript passes the initial evaluation, it is assigned to at least two independent experts for single-blind peer-review process. If the outcomes of the performed reviews are opposite, the third review is required. The peer-review outcomes are one of following:
RESEARCH AND PUBLICATION ETHICS
Research Involving Human Subjects
When reporting on research that involves human subjects, human material, human tissues, or human data, authors must declare that the investigation was carried out following the rules of the Declaration of Helsinki of 1975 (https://www.wma.net/what-we-do/medical-ethics/declaration-of-helsinki/), revised in 2013. As a minimum, a statement including number of approval and name of the ethics committee must be stated in Section ‘Statement of Human Rights’ of the article. In addition, the protection of privacy is a legal right that must not be breached without individual informed consent. In cases where the identification of personal information is necessary for scientific reasons, authors should obtain full documentation of informed consent, including written permission from the patient prior to inclusion in the study.
Example of Statement of Human Rights: “The study was conducted in accordance with the Declaration of Helsinki, and the protocol was approved by the Ethics Committee of Name of the Institution (No. number of approval).”
Example of Statement of Informed Consent: “All subjects gave their informed consent for inclusion before they participated in the study”.
For non-interventional studies (e.g. surveys, questionnaires, social media research), all participants must be fully informed if the anonymity is assured, why the research is being conducted, how their data will be used and if there are any risks associated. As with all research involving humans, ethical approval from an appropriate ethics committee must be obtained prior to conducting the study.
Research involving Animals
When reporting on research that involves animal subjects, animal material or animal tissues, authors must declare that the investigation was carried out following the rules of the European Directive for the welfare of laboratory animals (No. 2010/63/EU) and national and institutional regulations. As a minimum, a statement including number of approval and name of the ethics committee must be stated in Section ‘Statement of Animal Rights’ of the article. Statements on animal welfare should confirm that the study complied with all relevant legislation. Also, authors must include details on housing, husbandry and pain management in their manuscript (section Materials and methods).
Example of Statement of Animal Rights: “All research procedures were carried out in strict accordance with the European Union Directive for the welfare of laboratory animals (No. 2010/63/EU) and approved by the Ethics Committee of Name of the Institution (No. number of approval).”

Peer Review Process

All submitted manuscripts received by the Editorial Office will be evaluated by a professional Editorial board to determine whether they posses sufficient quality, are they properly prepared and follow the ethical policies of Ser J Exp Clin Res. Manuscripts that do not fit with the quality and ethical standards of Ser J Exp Clin Res will be rejected before peer- review. Manuscripts that are not properly prepared according to the Instruction for authors will be returned to the authors for revision and resubmission.
Once a manuscript passes the initial evaluation, it will be assigned to at least two independent experts for single-blind peer-review process. If the outcomes of the performed reviews are opposite, the third review is required. The peer-review outcomes are one of following:
  • Accept (without any changes) - the journal will publish the paper in its original form. This type of decision outcome is rare.
  • Minor revision - the manuscript have high chance to be accepted after fulfillment of minor corrections. Authors will be asked to resubmit the revised manuscript within a suitable time frame, and the revised version will be returned to the reviewer for further comments.
  • Reconsider after Major Revision - the acceptance of the manuscript would depend on the revisions. The authors are required to perform extensive and significant improvements in their manuscript. Authors will be asked to resubmit the revised manuscript within a suitable time frame, and the revised version will be returned to the reviewer for further comments.
  • Reject - the manuscript is rejected for two reasons: 1. it has serious flaws, and/or makes no original significant contribution; 2. corrections and improvements during the (major) revision were not sufficient and satisfactory. No offer of resubmission to the journal is provided.
All reviewer comments should be responded point-by-point in a separate document entitled ‘Answers to reviewers comments’. Corrections should be marked within the text in a red colour or as a track changes. During the submission process, author should suggest two potential reviewers with the appropriate expertise to review the manuscript. Proposed reviewers should be from different institutions than the authors.
Upon editor’s approval, after received positive manuscript reviews, the manuscript is accepted in the system, and the corresponding author receives information about the manuscript accepted for publication to the email address. Once accepted, the manuscript will undergo professional copy-editing, English editing, proofreading by the authors, pagination and publication. The Editorial board reserves the right to correct the English language after proofreading by the authors.
DOI number is assigned to the paper and, after proofreading and text break according to the Journal instructions, the paper is published as Ahead of Print first on Sciendo platform and then in one of the next issues of the Journal.


Publishing Policy

Serbian Journal of Experimental and Clinical Research (Ser J Exp Clin Res) strictly adheres to the all aspects of best practice in publication. The journal strictly follows the policies of the International Committee of Medical Journal Editors (ICMJE) and publishing ethics guidelines provided by the Committee on Publication Ethics (COPE).
OPPENESS
Authorship
All contributors who have made a significant contribution should be given chance to be cited as authors. Other individuals who have contributed to the work should be acknowledged. Articles should include a full list of the current institutional affiliations of all authors, both academic and corporate.
Competing interests
All authors, referees and editors must declare any conflicting or competing interests relating to a given article. Competing interests through their potential influence on behaviour or content or perception may undermine the objectivity, integrity or perceived value of publication.
Sources of funding
Funding received for the work described in the paper or for the publication itself, for all authors, must be declared within the publication.
RESEARCH AND PUBLICATION ETHICS
Research Involving Human Subjects
When reporting on research that involves human subjects, human material, human tissues, or human data, authors must declare that the investigation was carried out following the rules of the Declaration of Helsinki of 1975, revised in 2013. As a minimum, a statement including number of approval and name of the ethics committee must be stated in Section ‘Statement of Human Rights’ of the article. In addition, the protection of privacy is a legal right that must not be breached without individual informed consent. In cases where the identification of personal information is necessary for scientific reasons, authors should obtain full documentation of informed consent, including written permission from the patient prior to inclusion in the study.
Example of Statement of Human Rights: “The study was conducted in accordance with the Declaration of Helsinki, and the protocol was approved by the Ethics Committee of Name of the Institution (No. number of approval).”
Example of Statement of Informed Consent: “All subjects gave their informed consent for inclusion before they participated in the study”.
For non-interventional studies (e.g. surveys, questionnaires, social media research), all participants must be fully informed if the anonymity is assured, why the research is being conducted, how their data will be used and if there are any risks associated. As with all research involving humans, ethical approval from an appropriate ethics committee must be obtained prior to conducting the study.
Research involving Animals
When reporting on research that involves animal subjects, animal material or animal tissues, authors must declare that the investigation was carried out following the rules of the European Directive for the welfare of laboratory animals (No. 2010/63/EU) and national and institutional regulations. As a minimum, a statement including number of approval and name of the ethics committee must be stated in Section ‘Statement of Animal Rights’ of the article. Statements on animal welfare should confirm that the study complied with all relevant legislation. Also, authors must include details on housing, husbandry and pain management in their manuscript (section Materials and methods).
Example of Statement of Animal Rights: “All research procedures were carried out in strict accordance with the European Union Directive for the welfare of laboratory animals (No. 2010/63/EU) and approved by the Ethics Committee of Name of the Institution (No. number of approval).”
SUBMISSION PROCESS
Manuscripts submitted to Ser J Exp Clin Res must neither be published previously nor be under consideration for publication in another journal. Manuscripts are acompanied with a suitable cover letter stating that: the manuscript is not submitted for publication elsewhere; all authors have agreed to submission; the study is carried out in accordance with relevant ethical international guidelines.
Ser J Exp Clin Res considers only manuscripts written in English using Microsoft Office Word format and uploaded online at https://www.editorialmanager.com/sjecr/.
PLAGIARSIM
Plagiarism, data fabrication and image manipulation are not tolerated. Plagiarism includes copying text, ideas, images, or data from another source, even from authors own publications, without providing any reference to the original source. If a study's design or the manuscript's structure or language has been inspired by previous works, these papers must be explicitly cited. All manuscripts submitted to Ser J Exp Clin Res are checked for plagiarism prior to the first step of the editorial process. The editorial board is participating in a growing community of Similarity Check System's users in order to ensure that the content published is original and trustworthy. Similarity Check is a medium that allows for comprehensive manuscripts screening, aimed to eliminate plagiarism and provide a high standard and quality peer-review process.
PEER REVIEW PROCESS
All submitted manuscripts received by the Editorial Office will be evaluated by a professional Editorial board to determine whether they posses sufficient quality, are they properly prepared and follow the ethical policies of Ser J Exp Clin Res. Manuscripts that do not fit with the quality and ethical standards of Ser J Exp Clin Res will be rejected before peer- review. Manuscripts that are not properly prepared according to the Instruction for authors will be returned to the authors for revision and resubmission.
Once a manuscript passes the initial evaluation, it will be assigned to at least two independent experts for single-blind peer-review process. If the outcomes of the performed reviews are opposite, the third review is required. The peer-review outcomes are one of following:
  • Accept (without any changes) - the journal will publish the paper in its original form. This type of decision outcome is rare.
  • Minor revision - the manuscript have high chance to be accepted after fulfillment of minor corrections. Authors will be asked to resubmit the revised manuscript within a suitable time frame, and the revised version will be returned to the reviewer for further comments.
  • Reconsider after Major Revision - the acceptance of the manuscript would depend on the revisions. The authors are required to perform extensive and significant improvements in their manuscript. Authors will be asked to resubmit the revised manuscript within a suitable time frame, and the revised version will be returned to the reviewer for further comments.
  • Reject - the manuscript is rejected for two reasons: 1. it has serious flaws, and/or makes no original significant contribution; 2. corrections and improvements during the (major) revision were not sufficient and satisfactory. No offer of resubmission to the journal is provided.
All reviewer comments should be responded point-by-point in a separate document entitled ‘Answers to reviewers comments’. Corrections should be marked within the text in a red colour or as a track changes. During the submission process, author should suggest two potential reviewers with the appropriate expertise to review the manuscript. Proposed reviewers should be from different institutions than the authors.
Upon editor’s approval, after received positive manuscript reviews, the manuscript is accepted in the system, and the corresponding author receives information about the manuscript accepted for publication to the email address. Once accepted, the manuscript will undergo professional copy-editing, English editing, proofreading by the authors, pagination and publication. The Editorial board reserves the right to correct the English language after proofreading by the authors.
DOI number is assigned to the paper and, after proofreading and text break according to the Journal instructions, the paper is published as Ahead of Print first on Sciendo platform (https://sciendo.com/journal/sjecr) and then in one of the next issues of the Journal.
COPYRIGHT POLICY
The journal is an Open Access journal that allows a free unlimited access to all its contents without any restrictions upon publication to all users. All articles published in Serbian Journal of Experimental and Clinical Research are published and distributed under the terms of the Creative Commons Attribution 4.0 International License, which permits reproduction, distribution, derives and commercial use, provided the original work is properly cited and authors and publisher are properly identified. On the following link Open Access License can be found: Open Access License
ARCHIVING POLICY
Sciendo archives the contents of this journal in Portico - digital long-term preservation service of scholarly books, journals and collections.
ARTICLE PROCESSING CHARGES (APCs)
The accepted manuscripts are published online first as Ahead of Print papers and are free of charge for authors.

Research and Publication Ethics

When reporting on research that involves human subjects, human material, human tissues, or human data, authors must declare that the investigation was carried out following the rules of the Declaration of Helsinki of 1975, revised in 2013. As a minimum, a statement including number of approval and name of the ethics committee must be stated in Section ‘Statement of Human Rights’ of the article. In addition, the protection of privacy is a legal right that must not be breached without individual informed consent. In cases where the identification of personal information is necessary for scientific reasons, authors should obtain full documentation of informed consent, including written permission from the patient prior to inclusion in the study.
Example of Statement of Human Rights: “The study was conducted in accordance with the Declaration of Helsinki, and the protocol was approved by the Ethics Committee of Name of the Institution(No. number of approval).”
Example of Statement of Informed Consent: “All subjects gave their informed consent for inclusion before they participated in the study”.
For non-interventional studies (e.g. surveys, questionnaires, social media research), all participants must be fully informed if the anonymity is assured, why the research is being conducted, how their data will be used and if there are any risks associated. As with all research involving humans, ethical approval from an appropriate ethics committee must be obtained prior to conducting the study.
Research involving Animals
When reporting on research that involves animal subjects, animal material or animal tissues, authors must declare that the investigation was carried out following the rules of the European Directive for the welfare of laboratory animals (No. 2010/63/EU) and national and institutional regulations. As a minimum, a statement including number of approval and name of the ethics committee must be stated in Section ‘Statement of Animal Rights’ of the article. Statements on animal welfare should confirm that the study complied with all relevant legislation. Also, authors must include details on housing, husbandry and pain management in their manuscript (section Materials and methods).
Example of Statement of Animal Rights: “All research procedures were carried out in strict accordance with the European Union Directive for the welfare of laboratory animals (No. 2010/63/EU) and approved by the Ethics Committee of Name of the Institution(No. number of approval).”
  1. Informed Consent Statement. In cases where the identification of personal information is necessary for scientific reasons, authors should obtain informed consent from all individuals included in the study
  2. Human Right Statement. Manuscripts containing information related to human should clearly state that the research has complied with all relevant international and national regulations and institutional policies and has been approved by the authors' institutional Ethics committee.
  3. Animal Right Statement. Manuscripts containing information related to animals should clearly state that the research has complied with all relevant international and national regulations and institutional policies and has been approved by the authors' institutional Ethics committee.

Curent Issue

Ahead of print

Issue Archives